NCT06904066
- Conditions
- Blood Cancer, Blood Protein Disorders, Bone Marrow Diseases, +42 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Leukemia, Myelomonocytic, Chronic
Explore clinical trials studying Leukemia, Myelomonocytic, Chronic. Study availability and eligibility vary by location and protocol.
417 public trials
60 recruiting studies
Leukemia, Myelomonocytic, Chronic trial results
NCT06566742
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
- Locations
-
- University of Miami Miami, Florida, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT07033598
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Winship Cancer Institute at Emory Atlanta, Georgia, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT07302776
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +21 more
- Locations
-
- Stanford University Palo Alto, California, United States
NCT07143669
- Conditions
- Autonomic Nervous System Diseases, Bone Marrow Diseases, Chronic Disease, +29 more
- Locations
-
- AllerVie Clinical Research Birmingham, Alabama, United States
- O'Neal Comprehensive Cancer Center at the UAB Birmingham, Alabama, United States
- Kaiser Permanente San Diego San Diego, California, United States
- Allergy & Asthma Clinical Research of the Bay Area Walnut Creek, California, United States
Recruiting
Pacritinib in CMML
NCT06159491
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +11 more
- Locations
-
- The Mount Sinai Hospital New York, United States
NCT04708054
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
NCT03383575
- Conditions
- Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +22 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Cleveland Clinic Foundation Cleveland, Ohio, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT05092451
- Conditions
- Acute Myeloid Leukemia (AML), B-cell Lymphoma, Blastic Transformation of Chronic Myeloid Leukemia, +39 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04996875
- Conditions
- Advanced Systemic Mastocytosis (AdvSM), Aggressive Systemic Mastocytosis (ASM), Bone Marrow Diseases, +35 more
- Locations
-
- University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
- Mayo Clinic Arizona Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States